Global Bispecific Antibody Market Sales Size Increase 280% in 2019
The sales of bispecific antibody products in 2019 rose by 280% in 2019 driven by 500% increase in sales of Hemlibra , as per recently published research report “Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026”.
“Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026” Report Highlights:
- Global Bispecific Antibody Market Opportunity: > US$ 10 Billion
- Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019)
- Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion)
- Global Bispecific Antibody Pipeline: 333 Drug
- Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra)
- Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & > 80%
Download Report:
“Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026” provides comprehensive insight on clinical and non-clinical factors that are driving the global bispecific antibodies market and its impact on the global pharmaceutical market landscape. The report has been prepared in a view to deeply profile the current market trends along with the sales insight on two (Blincyto & Hemlibra) commercially available bispecific antibodies with their regional level revenue, market share and the clinical profile.
Contact:
Neeraj Chawla
neeraj@kuickresearch.com
+91-11-47067990
